Phosphates de calcium : Questions médicales fréquentes
Nom anglais: Calcium Phosphates
Descriptor UI:D002130
Tree Number:D01.695.625.675.650.075
Termes MeSH sélectionnés :
Diagnostic and Statistical Manual of Mental Disorders
Questions fréquentes et termes MeSH associés
Diagnostic
5
#1
Comment diagnostiquer une carence en phosphates de calcium ?
Un diagnostic se fait par des analyses sanguines mesurant les niveaux de calcium et de phosphates.
Carence en calciumPhosphates
#2
Quels tests sont utilisés pour évaluer les phosphates de calcium ?
Les tests sanguins et urinaires mesurent les niveaux de calcium et de phosphates.
Tests de laboratoireCalcium
#3
Quels symptômes indiquent un excès de phosphates de calcium ?
Des symptômes comme des douleurs osseuses, des démangeaisons et des troubles digestifs peuvent apparaître.
HyperphosphatémieSymptômes
#4
Comment évaluer la santé osseuse liée aux phosphates ?
Des examens d'imagerie comme la densitométrie osseuse peuvent être réalisés.
Densitométrie osseuseSanté osseuse
#5
Quels marqueurs biologiques sont liés aux phosphates de calcium ?
Les niveaux de parathormone et de vitamine D sont des marqueurs importants à surveiller.
ParathormoneVitamine D
Symptômes
5
#1
Quels sont les symptômes d'une carence en phosphates de calcium ?
Les symptômes incluent des douleurs osseuses, des faiblesses musculaires et des fractures fréquentes.
Carence en calciumDouleurs osseuses
#2
Comment reconnaître une hyperphosphatémie ?
Des démangeaisons, des douleurs articulaires et des éruptions cutanées peuvent survenir.
HyperphosphatémieSymptômes
#3
Quels signes indiquent un déséquilibre phosphocalcique ?
Des signes incluent des crampes musculaires, des troubles de la croissance et des anomalies dentaires.
Déséquilibre électrolytiqueCroissance
#4
Quels symptômes sont liés à une surconsommation de phosphates ?
Une surconsommation peut entraîner des nausées, des vomissements et des douleurs abdominales.
SurconsommationNausées
#5
Quels symptômes peuvent affecter les reins ?
Une accumulation de phosphates peut causer des douleurs rénales et des calculs rénaux.
Calculs rénauxDouleurs rénales
Prévention
5
#1
Comment prévenir une carence en phosphates de calcium ?
Une alimentation équilibrée riche en produits laitiers et légumes verts est essentielle.
PréventionAlimentation
#2
Quels conseils nutritionnels pour éviter l'hyperphosphatémie ?
Limiter les aliments riches en phosphates et augmenter l'hydratation peut aider.
NutritionHydratation
#3
Comment le mode de vie influence-t-il les niveaux de phosphates ?
Un mode de vie actif et une bonne hydratation favorisent un équilibre phosphocalcique.
Mode de vieHydratation
#4
Quels exercices sont bénéfiques pour la santé osseuse ?
Des exercices de résistance et de port de poids renforcent les os et améliorent la santé.
ExerciceSanté osseuse
#5
Comment surveiller les niveaux de phosphates chez les patients à risque ?
Des contrôles réguliers des niveaux sanguins de calcium et de phosphates sont recommandés.
SurveillanceRisque
Traitements
5
#1
Comment traiter une carence en phosphates de calcium ?
Le traitement inclut des suppléments de phosphates et une alimentation riche en calcium.
Suppléments de calciumAlimentation
#2
Quels médicaments sont utilisés pour l'hyperphosphatémie ?
Des chélateurs de phosphates et des médicaments à base de calcium peuvent être prescrits.
ChélateursMédicaments
#3
Comment gérer les déséquilibres phosphocalciques ?
La gestion implique des ajustements alimentaires et des traitements médicaux adaptés.
Gestion des déséquilibresAlimentation
#4
Quels traitements sont efficaces pour les douleurs osseuses ?
Des analgésiques et des anti-inflammatoires peuvent soulager les douleurs osseuses.
AnalgésiquesAnti-inflammatoires
#5
Comment prévenir les complications liées aux phosphates ?
Un suivi régulier et une alimentation équilibrée aident à prévenir les complications.
PréventionComplications
Complications
5
#1
Quelles complications peuvent survenir avec une carence en phosphates ?
Des complications incluent des fractures osseuses, des déformations et des douleurs chroniques.
ComplicationsFractures
#2
Quels risques sont associés à l'hyperphosphatémie ?
L'hyperphosphatémie peut entraîner des calcifications des tissus et des maladies rénales.
HyperphosphatémieMaladies rénales
#3
Comment les déséquilibres phosphocalciques affectent-ils la santé ?
Ils peuvent provoquer des troubles osseux, des douleurs et des problèmes métaboliques.
DéséquilibresSanté
#4
Quelles sont les complications à long terme d'une mauvaise gestion ?
Une mauvaise gestion peut entraîner des maladies osseuses chroniques et des douleurs persistantes.
Maladies chroniquesGestion
#5
Quels effets l'excès de phosphates a-t-il sur le cœur ?
Un excès de phosphates peut augmenter le risque de maladies cardiovasculaires.
Maladies cardiovasculairesExcès
Facteurs de risque
5
#1
Quels facteurs augmentent le risque de carence en phosphates ?
Les régimes alimentaires pauvres, certaines maladies et des médicaments peuvent augmenter le risque.
Facteurs de risqueRégime alimentaire
#2
Comment l'âge influence-t-il les niveaux de phosphates ?
Avec l'âge, l'absorption des phosphates peut diminuer, augmentant le risque de carence.
ÂgeAbsorption
#3
Quels médicaments peuvent affecter les niveaux de phosphates ?
Certains diurétiques et médicaments antiacides peuvent perturber l'équilibre phosphocalcique.
MédicamentsDiurétiques
#4
Comment les maladies rénales influencent-elles les phosphates ?
Les maladies rénales peuvent entraîner une rétention de phosphates, augmentant le risque d'hyperphosphatémie.
Maladies rénalesHyperphosphatémie
#5
Quels comportements alimentaires sont des facteurs de risque ?
Une consommation excessive de produits transformés riches en phosphates est un facteur de risque.
Comportements alimentairesProduits transformés
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Phosphates de calcium : Questions médicales les plus fréquentes",
"headline": "Phosphates de calcium : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Phosphates de calcium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-24",
"dateModified": "2025-03-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Phosphates de calcium"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phosphates",
"url": "https://questionsmedicales.fr/mesh/D010710",
"about": {
"@type": "MedicalCondition",
"name": "Phosphates",
"code": {
"@type": "MedicalCode",
"code": "D010710",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.695.625.675.650"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apatites",
"alternateName": "Apatites",
"url": "https://questionsmedicales.fr/mesh/D001031",
"about": {
"@type": "MedicalCondition",
"name": "Apatites",
"code": {
"@type": "MedicalCode",
"code": "D001031",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.695.625.675.650.075.025"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hydroxyapatites",
"alternateName": "Hydroxyapatites",
"url": "https://questionsmedicales.fr/mesh/D006882",
"about": {
"@type": "MedicalCondition",
"name": "Hydroxyapatites",
"code": {
"@type": "MedicalCode",
"code": "D006882",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.695.625.675.650.075.025.300"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Durapatite",
"alternateName": "Durapatite",
"url": "https://questionsmedicales.fr/mesh/D017886",
"about": {
"@type": "MedicalCondition",
"name": "Durapatite",
"code": {
"@type": "MedicalCode",
"code": "D017886",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.695.625.675.650.075.025.300.150"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Durapatite",
"alternateName": "Durapatite",
"url": "https://questionsmedicales.fr/mesh/D017886",
"about": {
"@type": "MedicalCondition",
"name": "Durapatite",
"code": {
"@type": "MedicalCode",
"code": "D017886",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.695.625.675.650.075.025.300.150"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Phosphates de calcium",
"alternateName": "Calcium Phosphates",
"code": {
"@type": "MedicalCode",
"code": "D002130",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Helmut Cölfen",
"url": "https://questionsmedicales.fr/author/Helmut%20C%C3%B6lfen",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Universitätsstrasse 10, Box 714, 78457 Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "Hockin H K Xu",
"url": "https://questionsmedicales.fr/author/Hockin%20H%20K%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America; Center for Stem Cell Biology & Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD, 21201, United States of America; Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, 21201, United States of America. Electronic address: HXu2@umaryland.edu."
}
},
{
"@type": "Person",
"name": "Michael D Weir",
"url": "https://questionsmedicales.fr/author/Michael%20D%20Weir",
"affiliation": {
"@type": "Organization",
"name": "Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America. Electronic address: michael.weir@umaryland.edu."
}
},
{
"@type": "Person",
"name": "Abhishek Indurkar",
"url": "https://questionsmedicales.fr/author/Abhishek%20Indurkar",
"affiliation": {
"@type": "Organization",
"name": "Rudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka Street 3, LV-1007 Riga, Latvia."
}
},
{
"@type": "Person",
"name": "Rajan Choudhary",
"url": "https://questionsmedicales.fr/author/Rajan%20Choudhary",
"affiliation": {
"@type": "Organization",
"name": "Rudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka Street 3, LV-1007 Riga, Latvia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Validity of the revised Diagnostic and Statistical Manual of Mental Disorders-5 cross-cutting symptom measure as implemented in community mental health settings.",
"datePublished": "2023-10-14",
"url": "https://questionsmedicales.fr/article/37844781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2023.10.077"
}
},
{
"@type": "ScholarlyArticle",
"name": "Interrater reliability of criterion A of the alternative model for personality disorder (Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition-Section III): A meta-analysis.",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37227864",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000631"
}
},
{
"@type": "ScholarlyArticle",
"name": "Item Response Theory Analyses of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Criteria Adapted to Screen Use Disorder: Exploratory Survey.",
"datePublished": "2022-07-27",
"url": "https://questionsmedicales.fr/article/35896018",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/31803"
}
},
{
"@type": "ScholarlyArticle",
"name": "Psychopathy and antisocial personality disorder in the fifth edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders: An attempted replication of Wygant et al. (2016).",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37227862",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000626"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional impairment, insight, and comparison between criteria for gaming disorder in the International Classification of Diseases, 11 Edition and internet gaming disorder in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36326855",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1556/2006.2022.00079"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Produits chimiques inorganiques",
"item": "https://questionsmedicales.fr/mesh/D007287"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés du phosphore",
"item": "https://questionsmedicales.fr/mesh/D017553"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides du phosphore",
"item": "https://questionsmedicales.fr/mesh/D017976"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acides phosphoriques",
"item": "https://questionsmedicales.fr/mesh/D010756"
},
{
"@type": "ListItem",
"position": 6,
"name": "Phosphates",
"item": "https://questionsmedicales.fr/mesh/D010710"
},
{
"@type": "ListItem",
"position": 7,
"name": "Phosphates de calcium",
"item": "https://questionsmedicales.fr/mesh/D002130"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Phosphates de calcium - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Phosphates de calcium",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Phosphates de calcium",
"description": "Comment diagnostiquer une carence en phosphates de calcium ?\nQuels tests sont utilisés pour évaluer les phosphates de calcium ?\nQuels symptômes indiquent un excès de phosphates de calcium ?\nComment évaluer la santé osseuse liée aux phosphates ?\nQuels marqueurs biologiques sont liés aux phosphates de calcium ?",
"url": "https://questionsmedicales.fr/mesh/D002130?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Phosphates de calcium",
"description": "Quels sont les symptômes d'une carence en phosphates de calcium ?\nComment reconnaître une hyperphosphatémie ?\nQuels signes indiquent un déséquilibre phosphocalcique ?\nQuels symptômes sont liés à une surconsommation de phosphates ?\nQuels symptômes peuvent affecter les reins ?",
"url": "https://questionsmedicales.fr/mesh/D002130?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Phosphates de calcium",
"description": "Comment prévenir une carence en phosphates de calcium ?\nQuels conseils nutritionnels pour éviter l'hyperphosphatémie ?\nComment le mode de vie influence-t-il les niveaux de phosphates ?\nQuels exercices sont bénéfiques pour la santé osseuse ?\nComment surveiller les niveaux de phosphates chez les patients à risque ?",
"url": "https://questionsmedicales.fr/mesh/D002130?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Phosphates de calcium",
"description": "Comment traiter une carence en phosphates de calcium ?\nQuels médicaments sont utilisés pour l'hyperphosphatémie ?\nComment gérer les déséquilibres phosphocalciques ?\nQuels traitements sont efficaces pour les douleurs osseuses ?\nComment prévenir les complications liées aux phosphates ?",
"url": "https://questionsmedicales.fr/mesh/D002130?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Phosphates de calcium",
"description": "Quelles complications peuvent survenir avec une carence en phosphates ?\nQuels risques sont associés à l'hyperphosphatémie ?\nComment les déséquilibres phosphocalciques affectent-ils la santé ?\nQuelles sont les complications à long terme d'une mauvaise gestion ?\nQuels effets l'excès de phosphates a-t-il sur le cœur ?",
"url": "https://questionsmedicales.fr/mesh/D002130?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Phosphates de calcium",
"description": "Quels facteurs augmentent le risque de carence en phosphates ?\nComment l'âge influence-t-il les niveaux de phosphates ?\nQuels médicaments peuvent affecter les niveaux de phosphates ?\nComment les maladies rénales influencent-elles les phosphates ?\nQuels comportements alimentaires sont des facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D002130?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en phosphates de calcium ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par des analyses sanguines mesurant les niveaux de calcium et de phosphates."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les phosphates de calcium ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sanguins et urinaires mesurent les niveaux de calcium et de phosphates."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un excès de phosphates de calcium ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs osseuses, des démangeaisons et des troubles digestifs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment évaluer la santé osseuse liée aux phosphates ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens d'imagerie comme la densitométrie osseuse peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont liés aux phosphates de calcium ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de parathormone et de vitamine D sont des marqueurs importants à surveiller."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en phosphates de calcium ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs osseuses, des faiblesses musculaires et des fractures fréquentes."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hyperphosphatémie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des démangeaisons, des douleurs articulaires et des éruptions cutanées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un déséquilibre phosphocalcique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent des crampes musculaires, des troubles de la croissance et des anomalies dentaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une surconsommation de phosphates ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surconsommation peut entraîner des nausées, des vomissements et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent affecter les reins ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une accumulation de phosphates peut causer des douleurs rénales et des calculs rénaux."
}
},
{
"@type": "Question",
"name": "Comment prévenir une carence en phosphates de calcium ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en produits laitiers et légumes verts est essentielle."
}
},
{
"@type": "Question",
"name": "Quels conseils nutritionnels pour éviter l'hyperphosphatémie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Limiter les aliments riches en phosphates et augmenter l'hydratation peut aider."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il les niveaux de phosphates ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie actif et une bonne hydratation favorisent un équilibre phosphocalcique."
}
},
{
"@type": "Question",
"name": "Quels exercices sont bénéfiques pour la santé osseuse ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exercices de résistance et de port de poids renforcent les os et améliorent la santé."
}
},
{
"@type": "Question",
"name": "Comment surveiller les niveaux de phosphates chez les patients à risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des contrôles réguliers des niveaux sanguins de calcium et de phosphates sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en phosphates de calcium ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des suppléments de phosphates et une alimentation riche en calcium."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour l'hyperphosphatémie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des chélateurs de phosphates et des médicaments à base de calcium peuvent être prescrits."
}
},
{
"@type": "Question",
"name": "Comment gérer les déséquilibres phosphocalciques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique des ajustements alimentaires et des traitements médicaux adaptés."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces pour les douleurs osseuses ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analgésiques et des anti-inflammatoires peuvent soulager les douleurs osseuses."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux phosphates ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier et une alimentation équilibrée aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une carence en phosphates ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des fractures osseuses, des déformations et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à l'hyperphosphatémie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hyperphosphatémie peut entraîner des calcifications des tissus et des maladies rénales."
}
},
{
"@type": "Question",
"name": "Comment les déséquilibres phosphocalciques affectent-ils la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des troubles osseux, des douleurs et des problèmes métaboliques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications à long terme d'une mauvaise gestion ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise gestion peut entraîner des maladies osseuses chroniques et des douleurs persistantes."
}
},
{
"@type": "Question",
"name": "Quels effets l'excès de phosphates a-t-il sur le cœur ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un excès de phosphates peut augmenter le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de carence en phosphates ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les régimes alimentaires pauvres, certaines maladies et des médicaments peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il les niveaux de phosphates ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Avec l'âge, l'absorption des phosphates peut diminuer, augmentant le risque de carence."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent affecter les niveaux de phosphates ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains diurétiques et médicaments antiacides peuvent perturber l'équilibre phosphocalcique."
}
},
{
"@type": "Question",
"name": "Comment les maladies rénales influencent-elles les phosphates ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies rénales peuvent entraîner une rétention de phosphates, augmentant le risque d'hyperphosphatémie."
}
},
{
"@type": "Question",
"name": "Quels comportements alimentaires sont des facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une consommation excessive de produits transformés riches en phosphates est un facteur de risque."
}
}
]
}
]
}
Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America; Center for Stem Cell Biology & Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD, 21201, United States of America; Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, 21201, United States of America. Electronic address: HXu2@umaryland.edu.
Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America. Electronic address: michael.weir@umaryland.edu.
Rudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka Street 3, LV-1007 Riga, Latvia.
Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, Kipsalas Street 6A, LV-1048 Riga, Latvia.
Rudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka Street 3, LV-1007 Riga, Latvia.
Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, Kipsalas Street 6A, LV-1048 Riga, Latvia.
Rudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka Street 3, LV-1007 Riga, Latvia.
Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, Kipsalas Street 6A, LV-1048 Riga, Latvia.
Rudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka Street 3, LV-1007 Riga, Latvia.
Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, Kipsalas Street 6A, LV-1048 Riga, Latvia.
Division of Operative Dentistry, Department of General Dentistry, University of Maryland School of Dentistry, Baltimore, MD 21201, United States of America; Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America.
Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America.
Department of Advanced Production Engineering, Engineering and Technology Institute Groningen, Faculty of Science and Engineering , University of Groningen , Nijenborgh 4 , 9747 AG Groningen , The Netherlands.
Department of Biomedical Engineering-FB40, W.J. Kolff Institute for Biomedical Engineering and Materials Science-FB41, University Medical Center Groningen , University of Groningen , A. Deusinglaan 1 , 9713 AV Groningen , The Netherlands.
Department of Advanced Production Engineering, Engineering and Technology Institute Groningen, Faculty of Science and Engineering , University of Groningen , Nijenborgh 4 , 9747 AG Groningen , The Netherlands.
The purpose of this study was to validate the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) Cross-Cutting Symptom Measure (CCSM) as a screening tool for a wide variety of disorders w...
Participants (N = 851) were referred for coordinated specialty care services (mean age = 20.26 years (SD = 2.97); 82.5 % Caucasian, 7.5 % African American, 0.7 % Native American, 0.7 % Pacific Islande...
At optimal cut-score, specificity ranged from 57 to 77 % for depression, anxiety, substance use and psychosis domains; sensitivity ranged from 63 to 72 %. Scores for depression, anxiety, substance use...
Criterion measures did not have inter-rater reliabilities as this is generally prohibitive in clinic settings....
The CCSM could provide a first step in screening for multiple disorders; however, it cannot replace structured interviews for making diagnoses related to these conditions....
The alternative model for personality disorder (AMPD) is currently included in Section III of the Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition (DSM-5). This review sought to s...
Screen use is part of daily life worldwide and morbidity related to excess use of screens has been reported. Some use of screens in excess could indicate a screen use disorder (ScUD). An integrative a...
Our goals were (1) to describe screen uses in a general population sample and (2) to test the unidimensionality, local independence, and psychometric properties of the 9 Diagnostic and Statistical Man...
This cross-sectional survey in a French suburban city targeted adults and adolescents. A self-administered questionnaire covered the main types of screens used and their use for various activities in ...
Among the 300 participants, 171 (57.0%) were female (mean age 27 years), 297 (99.0%) used screens, 134 (44.7%) reported at least one criterion (potential problem users), and 5 (1.7%) reported 5 or mor...
We described screen uses in a French community sample and have shown that the adaptation of the DSM-5 IGD to "ScUD" has good psychometric validity and is discriminating, confirming our hypothesis. We ...
This study evaluated the consistency between the International Classification of Diseases, 11th Edition (ICD-11) for gaming disorder (ICD-11-GD) and Diagnostic and Statistical Manual of Mental Disorde...
We recruited 60 participants with GD, 45 participants who engaged in hazardous gaming (HG), and 120 controls based on a diagnostic interview. Their operationalization of functional impairment and stag...
We observed satisfactory consistency (kappa value = 0.80) with a diagnostic accuracy of 91.5% between the ICD-11-GD and DSM-5-IGD criteria. Furthermore, 16 participants with IGD in DSM-5 were determin...
There is a good consistency between ICD-11-GD and DSM-5-IGD criteria. The ICD-11 criteria have a high threshold for diagnosing GD. HG criteria could compensate for this high threshold and identify ind...
The conceptual basis of psychopathology within cancer survivorship is critical, as the chosen conceptualisation informs assessment and explanatory models, as well as interventions and supportive care ...
Age-related psychometric differences in Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) opioid use disorder (OUD) diagnostic criteria have been hypothesized, but not been te...
People who participated in the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions III and reported past 12-month nonmedical use of prescription opioids were included. YAs were 1...
One in 5 people met the DSM-5 OUD diagnostic criteria for OUD within the past 12 months, with the most endorsed criteria being tolerance (17.96%). DIF was identified for 3 criteria, including (1) taki...
These findings suggest that there may be age-related variations in the DSM-5 OUD diagnostic criteria's ability to detect latent OUD. Future research should identify contributing factors and the influe...
There is a scarcity of summarizing data on the epidemiology of insomnia in older persons, especially when diagnosed with international criteria. This study aimed to estimate the prevalence and correla...
Through PubMed/MEDLINE, EMBASE, and Web of Science (WoS), we searched for relevant articles published before June 28, 2023. The risk of bias was weighed using the Joanna Briggs Institute's (JBI's) cri...
We included 18,270 participants across 16 studies. The male/female ratio was 0.89 (12 studies), and the mean age varied from 65.9 to 83.1 years (8 studies). The pooled prevalence of insomnia was 19.6%...
Nearly one in every five old individuals was considered to have insomnia disorder, which was associated with the gender and the existence of mental health and/or somatic conditions....
We registered the protocol in the International Prospective Register of Systematic Reviews (PROSPERO) with registration number: CRD42022344675....
The alternative model of personality disorders (AMPD) traits were designed to maintain continuity with the Section II personality disorder (PD) diagnoses by retaining the same clinical information. Wh...
The Impact of Event Scale-Revised (IES-R) is a widely used self-report for assessing posttraumatic stress disorder (PTSD), originally aligned with Diagnostic and Statistical Manual of Mental Disorders...
A total of 238 participants recruited from multiple psychiatric centers, including 67 patients with PTSD, 72 patients with psychiatric controls, and 99 healthy controls, were included in the study. Al...
The IES-R demonstrated good internal consistency and a high correlation with the PCL-5. Through factor analysis, 5 distinct dimensions emerged within the IES-R: sleep disturbance, intrusion, hyperarou...
These findings underscore the scale's concurrent validity with the DSM-5 PTSD criteria and its effectiveness as a screening tool. Implementing a cutoff score of 25 on the IES-R can enhance its utility...